AKT1 and cholangiocarcinoma: Moreover, phosphorylated AKT has become a biomarker for mTORC2 activation [77], and the mechanism that triggers mTORC2 activation in CCA and HCC is not yet known; notably, a few studies indicate that it is related to copy number gain of RICTOR [78].